CD73 is associated with poor prognosis in high-grade serous ovarian cancer

MLA

Gregory M. Chen, et al. “CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer.” Cancer Research, vol. 75, no. 21, Dec. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....677786f11991bc456bc46ef3d2d102e6&authtype=sso&custid=ns315887.

APA

Gregory M. Chen, Diane Provencher, Thomas Karn, John Stagg, Joshy George, Isabelle Cousineau, Martin Turcotte, Kurosh Rahimi, Sandra Pommey, Deena M.A. Gendoo, Cécile Le Page, Anne Marie Mes-Masson, Benjamin Haibe-Kains, Guillaume Chouinard, & Kathleen Spring. (2014). CD73 is associated with poor prognosis in high-grade serous ovarian cancer. Cancer Research, 75(21).

Chicago

Gregory M. Chen, Diane Provencher, Thomas Karn, John Stagg, Joshy George, Isabelle Cousineau, Martin Turcotte, et al. 2014. “CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer.” Cancer Research 75 (21). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....677786f11991bc456bc46ef3d2d102e6&authtype=sso&custid=ns315887.